share_log

TD Cowen Maintains Buy on Elevance Health, Lowers Price Target to $589

TD Cowen Maintains Buy on Elevance Health, Lowers Price Target to $589

TD Cowen維持對Elevance Health的買入評級,將目標價下調至589美元
Benzinga ·  07/19 12:42

TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and lowers the price target from $624 to $589.

TD Cowen分析師Ryan Langston維持對Elevance Health(紐交所:ELV)的買入評級,並將價格目標下調至589美元,原價爲624美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論